An appealing new agent for treating cholestatic pruritus

Affiliations

Comment

Albert Parés. Lancet. 2017.

. 2017 Mar 18;389(10074):1078-1080.

doi: 10.1016/S0140-6736(17)30320-3. Epub 2017 Feb 8.

¹ Liver Unit, Hospital Clínic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain. Electronic address: pares@ub.edu.

No abstract available

Comment on

Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
Hegade VS, Kendrick SF, Dobbins RL, Miller SR, Thompson D, Richards D, Storey J, Dukes GE, Corrigan M, Oude Elferink RP, Beuers U, Hirschfield GM, Jones DE. Hegade VS, et al. Lancet. 2017 Mar 18;389(10074):1114-1123. doi: 10.1016/S0140-6736(17)30319-7. Epub 2017 Feb 8. Lancet. 2017. PMID: 28187915 Clinical Trial.